Showing results (261-270 of 447) with videos related to
Sort By:
Pageof 45
Headache|July 29, 2017
Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment TrialDeborah I Friedman, Peter A Quiros, Prem S Subramanian, et al.The Journal of Headache and Pain|May 18, 2021
Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraineStephanie J Nahas, Nada Hindiyeh, Deborah I Friedman, et al.Neurology|January 23, 2015
The effects of test-enhanced learning on long-term retention in AAN annual meeting coursesDouglas P Larsen, Andrew C Butler, Wint Y Aung, et al.Headache|September 2, 2025
Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timingRichard B Lipton, Jonathan Stokes, Christopher J Evans, et al.Pain Practice : the Official Journal of World Institute of Pain|August 13, 2008
Refractory headaches due to multilevel thoracic cerebrospinal fluid leaksTerrence L Trentman, Chiwai E Chan, Naresh P Patel, et al.Brain Communications|April 15, 2021
Subconcussive brain vital signs changes predict head-impact exposure in ice hockey playersShaun D Fickling, Aynsley M Smith, Michael J Stuart, et al.Headache|May 5, 2016
Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyDavid W Dodick, Elizabeth W Loder, Aubrey Manack Adams, et al.Cephalalgia : an International Journal of Headache|August 15, 2020
[123I]-IMP single-photon emission computed tomography imaging in visual snow syndrome: A case seriesMamoru Shibata, Kei Tsutsumi, Yu Iwabuchi, et al.The Journal of Headache and Pain|April 26, 2022
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trialsRichard B Lipton, Rashmi B Halker Singh, Dennis A Revicki, et al.Mayo Clinic Proceedings|January 5, 2024
Pharmacotherapies for Migraine and Translating Evidence From Bench to BedsideMessoud Ashina, Jan Hoffmann, Håkan Ashina, et al.Pageof 45